Status:
COMPLETED
Individualized Lifestyle Intervention for Obesity Management Based on Obesity Phenotypes
Lead Sponsor:
Mayo Clinic
Conditions:
Obesity
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this protocol is to define an "individualized diet" approach based on obesity related phenotypes (pathophysiology obesity classification), which would increase weight loss, adherence, a...
Eligibility Criteria
Inclusion
- Adults with obesity (BMI \>30Kg/m2); these will be otherwise healthy individuals with no unstable psychiatric disease and uncontrolled life-threatening comorbidities (i.e. unstable angina).
- Age: 18-65 years.
- Gender: Men or women.
Exclusion
- Weight change greater than 3% in the previous 3 months (weight stable).
- History of bariatric surgery including lap band and bariatric endoscopy.
- Significant untreated psychiatric dysfunction including binge eating disorders and bulimia.
- Current use of anti-obesity pharmacotherapy, medications known to affect weight (e.g., corticosteroids) or GLP-1 agonist/analog for T2DM
- A positive score on the AUDIT-C questionnaire as judged by an investigator.
- Patient has a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder study adherence
Key Trial Info
Start Date :
July 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2022
Estimated Enrollment :
215 Patients enrolled
Trial Details
Trial ID
NCT04073394
Start Date
July 6 2020
End Date
January 31 2022
Last Update
February 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905